Literature DB >> 16944930

Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation.

Francois-Pierre J Martin1, Elena F Verdu, Yulan Wang, Marc-Emmanuel Dumas, Ivan K S Yap, Olivier Cloarec, Gabriela E Bergonzelli, Irene Corthesy-Theulaz, Sunil Kochhar, Elaine Holmes, John C Lindon, Stephen M Collins, Jeremy K Nicholson.   

Abstract

Irritable Bowel Syndrome (IBS) is a common multifactorial intestinal disorder for which the aetiology remains largely undefined. Here, we have used a Trichinella spiralis (T. spiralis)-induced model of post-infective IBS, and the effects of probiotic bacteria on gut dysfunction have been investigated using a metabonomic strategy. A total of 44 mice were divided into four groups: an uninfected control group and three T. spiralis-infected groups, one as infected control and the two other groups subsequently treated with either Lactobacillus paracasei (L. paracasei) NCC2461 in spent culture medium (SCM) or with L. paracasei-free SCM. Plasma, jejunal wall and longitudinal myenteric muscle samples were collected at day 21 post-infection. An NMR-based metabonomic approach characterized that the plasma metabolic profile of T. spiralis-infected mice showed an increased energy metabolism (lactate, citrate, alanine), fat mobilization (acetoacetate, 3-D-hydroxybutyrate, lipoproteins) and a disruption of amino acid metabolism due to increased protein breakdown, which were related to the intestinal hypercontractility. Increased levels of taurine, creatine and glycerophosphorylcholine in the jejunal muscles were associated with the muscular hypertrophy and disrupted jejunal functions. L. paracasei treatment normalized the muscular activity and the disturbed energy metabolism as evidenced by decreased glycogenesis and elevated lipid breakdown in comparison with untreated T. spiralis-infected mice. Changes in the levels of plasma metabolites (glutamine, lysine, methionine) that might relate to a modulation of immunological responses were also observed in the presence of the probiotic treatment. The work presented here suggests that probiotics may be beneficial in patients with IBS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944930     DOI: 10.1021/pr060157b

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  24 in total

Review 1.  Clinical metabolomics paves the way towards future healthcare strategies.

Authors:  Sebastiano Collino; François-Pierre J Martin; Serge Rezzi
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues.

Authors:  Olaf Beckonert; Muireann Coen; Hector C Keun; Yulan Wang; Timothy M D Ebbels; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-05-13       Impact factor: 13.491

3.  Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.

Authors:  Hamid Noorbakhsh; Masoud Yavarmanesh; Seyed Ali Mortazavi; Peyman Adibi; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2018-11-03       Impact factor: 5.614

4.  Host-parasite interactions revealed by Plasmodium falciparum metabolomics.

Authors:  Kellen L Olszewski; Joanne M Morrisey; Daniel Wilinski; James M Burns; Akhil B Vaidya; Joshua D Rabinowitz; Manuel Llinás
Journal:  Cell Host Microbe       Date:  2009-02-19       Impact factor: 21.023

5.  Gut bacteria in health and disease.

Authors:  Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-09

6.  Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome.

Authors:  Kajsa Kajander; Eveliina Myllyluoma; Sinikka Kyrönpalo; Martin Rasmussen; Pentti Sipponen; Ismo Mattila; Tuulikki Seppänen-Laakso; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

7.  Systems parasitology: effects of Fasciola hepatica on the neurochemical profile in the rat brain.

Authors:  Jasmina Saric; Jia V Li; Jürg Utzinger; Yulan Wang; Jennifer Keiser; Stephan Dirnhofer; Olaf Beckonert; Mansour T A Sharabiani; Judith M Fonville; Jeremy K Nicholson; Elaine Holmes
Journal:  Mol Syst Biol       Date:  2010-07       Impact factor: 11.429

8.  Probiotics for the control of parasites: an overview.

Authors:  Marie-Agnès Travers; Isabelle Florent; Linda Kohl; Philippe Grellier
Journal:  J Parasitol Res       Date:  2011-09-28

9.  Panorganismal metabolic response modeling of an experimental Echinostoma caproni infection in the mouse.

Authors:  Jasmina Saric; Jia V Li; Yulan Wang; Jennifer Keiser; Kirill Veselkov; Stephan Dirnhofer; Ivan K S Yap; Jeremy K Nicholson; Elaine Holmes; Jürg Utzinger
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

Review 10.  Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome.

Authors:  Pamela Vernocchi; Lucia Vannini; Davide Gottardi; Federica Del Chierico; Diana I Serrazanetti; Maurice Ndagijimana; Maria E Guerzoni
Journal:  Front Cell Infect Microbiol       Date:  2012-12-11       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.